Business context and reporting period
ESCO Technologies Inc. (NYSE: ESE) filed this Form 10-K for the fiscal year ended September 30, 2023. ESCO supplies engineered products and services through Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The filing reports full-year results; it does not provide a separate fiscal fourth-quarter income statement.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Net sales | $956.0 million | $857.5 million |
| Net earnings | $92.5 million | $82.3 million |
| Diluted EPS, GAAP | $3.58 | $3.16 |
| EBIT | $127.7 million | $111.3 million |
| EBIT margin | 13.4% | 13.0% |
| Gross margin | 39.3% | 38.7% |
| Net cash from operating activities | $76.9 million | $135.3 million |
- Sales increased 11.5%; net earnings rose 12.4%. GAAP diluted EPS increased 13.3%. Adjusted diluted EPS, a non-GAAP measure, was $3.70 versus $3.21.
- Segment sales: A&D $392.4 million (+11.7%); USG $342.3 million (+23.0%); Test $221.3 million (−2.8%). Segment EBIT was $71.6 million, $76.7 million, and $32.4 million, respectively.
- Orders were $1.033 billion, for a 1.08x book-to-bill ratio. Year-end backlog was $772.4 million, up 11.1% from $695.0 million; approximately 70% was expected to be completed in FY2024.
- Working capital was $266.4 million, versus $254.5 million. Cash was $41.9 million and total debt $102.0 million, for net debt of approximately $60.1 million. The company reported $390 million of available borrowing capacity under its credit facility.
- Operating cash flow fell to $76.9 million, primarily from higher working-capital needs and tax and interest payments. Investing cash use was $52.5 million, including $22.4 million of capital expenditures and $12.4 million of capitalized software. Financing cash use was $78.3 million, primarily reflecting debt paydown.
- Interest expense rose to $8.8 million from $4.9 million; the weighted-average borrowing rate increased to 5.82% from 2.11%. The effective tax rate was 22.2%, compared with 22.7%.
- The company paid $0.32 per share in dividends, totaling $8.3 million, and repurchased approximately 140,000 shares for $12.4 million.
Material changes, outlook, and risks
- USG growth reflected higher shipments and service revenue at Doble and increased wind and solar product shipments at NRG. A&D benefited from commercial aerospace recovery. Test revenue was affected by COVID-related disruptions in China, partly offset by European project timing.
- Management described its financial position and liquidity as strong and expected operating cash flow and credit-facility borrowings to meet capital and operating needs over the next 12 months and foreseeable future. The filing provides no quantified FY2024 revenue or earnings guidance.
- ESCO acquired CMT Materials in February 2023 for approximately $18 million net of acquired cash; it contributed about $10 million of FY2023 revenue. After year-end, ESCO acquired MPE Limited on November 9, 2023, for approximately $57 million; MPE will join the Test segment.
- ESCO entered a new five-year, $500 million revolving credit facility, maturing August 30, 2028, with a lender-consent option to increase commitments by $250 million. It was in compliance with facility covenants at year-end. Management classified $20 million of debt as current, intending repayment within 12 months, although repayment was not contractually required during that period.
- Contract estimate adjustments reduced FY2023 earnings before tax by approximately $14.0 million and diluted EPS by $0.43. Other identified adjustments underlying adjusted EPS included executive transition and acquisition costs, CMT purchase-accounting charges, and restructuring charges. Management reported no goodwill or long-lived asset impairment.
- Key risks include government funding and contract termination, fixed-price contract cost overruns, supply-chain concentration and input-cost inflation, international political and currency exposure, cybersecurity, product liability, environmental matters, and acquisition integration. Management stated current litigation and environmental exposures were adequately reserved, insured, or not expected to materially affect results; ultimate outcomes remain uncertain.
- Audit reports expressed unqualified opinions on the financial statements and internal control over financial reporting. The auditor identified estimation of costs to complete certain A&D long-term contracts as a critical audit matter.
Important facts for investors to verify
- Whether operating cash flow recovers as receivables, inventories, and contract balances convert to cash.
- Whether the higher backlog converts to revenue on schedule, especially government-linked orders and fixed-price contracts; assess the disclosed $14.0 million contract-estimate impact.
- Whether USG growth and profitability persist, and whether Test performance improves as China-related disruption eases.
- How the MPE acquisition is funded and integrated, and whether expected benefits justify the purchase price and added goodwill and intangible assets.
- Debt repayment plans, borrowing costs, covenant headroom, and the capacity to sustain dividends and share repurchases.